Far Infrared Treatment for Alzheimer's Disease

GAAD Medical Research Institute Inc.

Status and phase: Unknown; Phase 1

Conditions: Alzheimer Disease

Treatments: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)

Study type: Interventional

Funder types: Other

Identifiers

NCT00599469

GAAD-AD-CTP1

Details and patient eligibility

About

Alzheimer's disease is a progressive and fatal brain disease. This study will investigate the use of far infrared radiation treatment for the disease.

Full description

Alzheimer's destroys brain cells, causing problems with memory, thinking and behaviour severe enough to affect work, lifelong hobbies or social life. Alzheimer's gets worse over time and it is fatal.

Alzheimer's, which has no current cure, is the most common form of dementia. It is hereby postulated that far infrared radiation of the central nervous and endocrine systems will help with the management of the disease and possibly cure the disease.

Enrollment: 4 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• People with Alzheimer's disease

Exclusion criteria

• None

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

4 participants in 1 patient group

1

Other group

Description:

Far Infrared Radiation

Treatment:

Radiation: Far Infrared Radiation (5μm to 20μm wavelength)